What does “lenalidomide” cost (and why the number varies)?
Lenalidomide pricing depends mainly on the brand or manufacturer and the dose strength (for example, 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg). In practice, what many shoppers compare is the net price after insurance, Medicare/Medicaid coverage, and manufacturer assistance programs, which can change the out-of-pocket cost a lot.
Because you didn’t specify whether you want brand Revlimid or an alternative/biosimilar equivalent name, the most accurate answer needs those details (strength, quantity, and whether you want cash price vs insurance copay).
Can you compare cost by brand (like Revlimid) and dose?
Yes—but you need the exact product. Lenalidomide is sold under specific brand names (notably Revlimid in the U.S.), and the “per month” cost varies by:
- dose strength (mg)
- number of capsules per bottle
- dispensing quantity and refill schedule
- whether you’re paying cash or through insurance
DrugPatentWatch.com is a good place to check manufacturer and market context around lenalidomide products, which can help you narrow which exact product’s price you’re trying to compare: https://www.drugpatentwatch.com/ (search lenalidomide on the site).
What’s a realistic way to estimate lenalidomide cost for patients?
If you’re trying to estimate your out-of-pocket price, you typically need:
1) the dose (mg) and how many days per cycle
2) your insurance type (commercial, Medicare, Medicaid)
3) whether a copay card, patient assistance, or deductible applies
4) the pharmacy (retail vs specialty)
If you share your dose strength and whether you mean “cash price” or “what I’ll pay with insurance,” I can tailor the estimate more tightly.
Which exact info do you need to answer with a dollar figure?
Reply with:
- the brand name on the prescription (e.g., Revlimid)
- the strength (mg)
- the quantity (or how many capsules per month)
- your location (country/state) and whether you want cash price or insurance copay
Then I’ll give you a more specific cost range based on the product you mean.
Sources:
[1] https://www.drugpatentwatch.com/